|
Those who posted before me are in tune with current research on this question. I can't tell for sure but I may be the only one posting so far who is Stage 1. I keep in mind the understanding that more than 50% of the women who are Stage 1 would never have a return of cancer if all they did was have surgery with clear margins.
Having said that, it is important to recognize that being HER2+ is SAID to be a reason to think we are among the less than 50% whose cancer would return if we don't go through additional therapy.
However, before I would jump on the bandwagon I want a good clear explanation from someone as to why oncologists continue to use HER2+ as a persuasive argument (if not a threatening stick) for why those of us who are HER2+ are more prone to have a recurrence, and yet as a group oncologists so far do not agree on that assumption strongly enough to list being HER2+ as a defining factor in the standards they specify as generally accepted practice for advising patients with bc about which therapy to have.
A.A.
|